Mitomycin (mitomycin): Reviews and patient testimonials

Mitomycin 10 mg powder for solution for injection/infusion or intravesical use

Mitomycin is used in palliative tumour therapy.

Mitomycin is administered intravenously as monochemotherapy or in combined cytostatic chemotherapy in the case of:

• advanced metastatic gastric carcinoma

• advanced and/or metastatic breast cancer

Furthermore mitomycin is administered intravenously in combined chemotherapy in the case of:

• non-small cell bronchial carcinoma

• advanced pancreatic carcinoma

Intravesical administration for relapse prevention in superficial urinary bladder carcinoma after transurethral resection.

Mitomycin 2 mg powder for solution for injection/infusion or intravesical use

Mitomycin is used in palliative tumour therapy.

Mitomycin is administered intravenously as monochemotherapy or in combined cytostatic chemotherapy in the case of:

• advanced metastatic gastric carcinoma

• advanced and/or metastatic breast cancer

Furthermore mitomycin is administered intravenously in combined chemotherapy in the case of:

• non-small cell bronchial carcinoma

• advanced pancreatic carcinoma

Intravesical administration for relapse prevention in superficial urinary bladder carcinoma after transurethral resection.

Mitomycin 20 mg, powder for solution for injection/infusion or intravesical use

Mitomycin is used in palliative tumour therapy.

Mitomycin is administered intravenously as monochemotherapy or in combined cytostatic chemotherapy in the case of:

• advanced metastatic gastric carcinoma

• advanced and/or metastatic breast cancer

Furthermore mitomycin is administered intravenously in combined chemotherapy in the case of:

• non-small cell bronchial carcinoma

• advanced pancreatic carcinoma

Intravesical administration for relapse prevention in superficial urinary bladder carcinoma after transurethral resection.

Mitomycin medac 20 mg, Powder and solvent for intravesical solution

Mitomycin medac is indicated as intravesical administration for relapse prevention in adult patients with superficial urinary bladder carcinoma after transurethral resection.

Mitomycin medac, 40 mg, Powder and solvent for intravesical solution

Mitomycin medac is indicated as intravesical administration for relapse prevention in adult patients with superficial urinary bladder carcinoma after transurethral resection.